StockData
Psyence Biomedical Ltd. logo

Psyence Biomedical Ltd. (PBM) stock

PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30
$4.12−0.10 (-2.37%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Psyence Biomedical r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2026 it was $1.47M, up 328.6% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Mar 31, 2026$1.47M+328.6%
FY2025Mar 31, 2025$342.17K-64.2%
FY2024Mar 31, 2024$954.59K-40.7%
FY2023Mar 31, 2023$1.61M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ3 2025Sep 30, 2025$357.44K–
Q2 FY2025CQ3 2024Sep 30, 2024$265.63K–

More Psyence Biomedical figures

See a number that looks wrong?